GSK Still Has Room To Run Despite Vaccine Cyclicality
Source: SeekingAlpha
2026-01-12 09:00:00 ET
...
Read the full article on Seeking Alpha
For further details see:
GSK Still Has Room To Run Despite Vaccine Cyclicality
GlaxoSmithKline Plc
NASDAQ: GLAXF
GLAXF Trading
-1.49% G/L:
$27.04 Last:
200 Volume:
$27.04 Open:
GLAXF Latest News
GLAXF Stock Data
$123,941,620,346
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London
